Home › Funds › AMERICAN CAPITAL MANAGEMENT INC › RGEN

AMERICAN CAPITAL MANAGEMENT INC position in RGEN

REPLIGEN CORP · Health Care

AMERICAN CAPITAL MANAGEMENT INC reported holding 280,313 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$53.9M, representing 2.82% of its reported portfolio and ranking #13 among its reported holdings. AMERICAN CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)280.31K sh
Reported value held$53.88M
Portfolio Weight2.82%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How AMERICAN CAPITAL MANAGEMENT INC's RGEN position evolved

AMERICAN CAPITAL MANAGEMENT INC first disclosed a stake in RGEN in Q3 2023 at 228,299 shares (US$36.3M). The position peaked in Q3 2024 at 379,034 shares, worth US$56.4M. Across 13 filings, AMERICAN CAPITAL MANAGEMENT INC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 280,313 shares valued at US$53.9M — a reduction of -80,742 shares quarter over quarter.. Notable position changes include a 48% increase in Q2 2024 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 228.30K $36.30M New
Q4 2023 232.55K $41.81M Add
Q1 2024 227.31K $41.81M Reduce
Q2 2024 336.70K $42.44M Add
Q3 2024 379.03K $56.41M Add
Q4 2024 383.53K $55.21M Add
Q1 2025 380.98K $48.48M Reduce
Q2 2025 329.28K $40.96M Reduce
Q3 2025 336.86K $45.03M Add
Q4 2025 335.12K $54.91M Reduce
Q1 2026 357.72K $42.15M Add
Q2 2026 361.06K $49.26M Add
Q3 2026 280.31K $53.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), MAVERICK CAPITAL LTD (US$272.5M), Maverick Capital (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has AMERICAN CAPITAL MANAGEMENT INC held RGEN?

AMERICAN CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AMERICAN CAPITAL MANAGEMENT INC's current position in RGEN?

As of Q3 2026, AMERICAN CAPITAL MANAGEMENT INC holds 280.31K shares of RGEN (REPLIGEN CORP), valued at $53.88M, representing 2.82% of its reported portfolio and ranking #13.

Has AMERICAN CAPITAL MANAGEMENT INC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), AMERICAN CAPITAL MANAGEMENT INC reduced its position in RGEN. The position peaked in Q3 2024 at 379.03K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, MAVERICK CAPITAL LTD, Maverick Capital, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.